Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases

Transplant Infectious Disease

Volumn 11, Issue 4, 2009, Pages 318-323

  Kohno, K ^a,b   Nagafuji, K ^a   Tsukamoto, H ^a   Horiuchi, T ^a   Takase, K ^a   Aoki, K ^a   Henzan, H ^a   Kamezaki, K ^a   Takenaka, K ^a   Miyamoto, T ^b   Teshima, T ^b   Harada, M ^a   Akashi, K ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adenovirus; Autoimmune disease; Autologous; Bacteremia; CD34 selected; Cytomegalovirus; Hematopoietic; Infection; Peripheral blood stem cells; Stem cell transplantation; Varicella zoster virus

Indexed keywords

ACICLOVIR; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYTOMEGALOVIRUS ANTIBODY; FOSCARNET; GANCICLOVIR; PENICILLIN G; PREDNISOLONE; STEROID; VALACICLOVIR; VANCOMYCIN;

ADENOVIRUS; ADENOVIRUS INFECTION; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; BACTERIAL INFECTION; CASE STUDY; CD34 SELECTION; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DERMATOMYOSITIS; DRUG MEGADOSE; DRUG PULSE THERAPY; FEBRILE NEUTROPENIA; FEMALE; GRANULOMA; HEMORRHAGIC CYSTITIS; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION RATE; INFECTIOUS COMPLICATION; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCLERODERMA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS REACTIVATION; WEGENER GRANULOMATOSIS;

ADENOVIRUSES, HUMAN; ADULT; ANTIGENS, CD34; AUTOIMMUNE DISEASES; BACTEREMIA; CYTOMEGALOVIRUS; DNA VIRUS INFECTIONS; FEMALE; HERPESVIRUS 3, HUMAN; HOSPITALS, UNIVERSITY; HUMANS; JAPAN; LISTERIA MONOCYTOGENES; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; STREPTOCOCCUS MITIS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 68849112839     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00401.x     Document Type: Article

References (35)

1. Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N Engl J Med 1997 337 (24) : 1777 1778.
2. Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000 356 (9231) : 701 707.
3. van Laar JM, Farge D, Tyndall A. Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis. Ann Rheum Dis 2005 64 : 1515.
4. Nash RA, McSweeney PA, Crofford LJ, et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007 110 (4) : 1388 1396.
5. Oyama Y, Barr WG, Statkute L, et al. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplant 2007 40 : 549 555.
6. Tsukamoto H, Nagafuji K, Horiuchi T, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis 2006 65 (4) : 508 514.
7. Holmberg LA, Boeckh M, Hooper H, et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 1999 94 (12) : 4029 4035.
8. Crippa F, Holmberg L, Carter RA, et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2002 8 (5) : 281 289.
9. Miyamoto T, Gondo H, Miyoshi Y, et al. Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma. Br J Haematol 1998 100 (2) : 348 350. (Pubitemid 28131069)
10. Witzens-Harig M, Heilmann C, Hensel M, et al. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells. Stem Cells 2007 25 (1) : 228 235.
11. Lin PC, Lee MY, Lin JT, Hsiao LT, Chen PM, Chiou TJ. Virus reactivation in high-risk non-Hodgkin's lymphoma patients after autologous CD34(+)-selected peripheral blood progenitor cell transplantation. Int J Hematol 2008 87 (4) : 434 439.
12. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002 34 : 730 751.
13. Takenaka K, Gondo H, Tanimoto K, et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplant 1997 19 (3) : 241 248.
14. Narimatsu H, Matsumura T, Kami M, et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005 11 : 429 436.
15. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002 34 (8) : 1094 1097.
16. Nagafuji K, Aoki K, Henzan H, et al. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2004 34 (10) : 909 914.
17. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002 34 (1) : 7 14.
18. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 5 (6) : 649 655.
19. Classen DC, Burke JP, Ford CD, et al. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am J Med 1990 89 : 441 446.
20. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001 33 (7) : 947 953.
21. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Clive J, Tutschka PJ. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998 21 (6) : 591 595. (Pubitemid 28138258)
22. Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R. Bacteremia due to viridans group Streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis 2002 34 (11) : 1469 1474.
23. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005 142 (12, Part 1) : 979 995.
24. Radice C, Munoz V, Castellares C, et al. Listeria monocytogenes meningitis in two allogeneic hematopoietic stem cell transplant recipients. Leuk Lymphoma 2006 47 (8) : 1701 1703.
25. Sullivan KM, Dykewicz CA, Longworth DL, et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program 2001 392 421.
26. Bilgrami S, Aslanzadeh J, Feingold JM, et al. Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance. Bone Marrow Transplant 1999 24 : 69 73.
27. Nagafuji K, Eto T, Hayashi S, Tokunaga Y, Gondo H, Niho Y. Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplant 1998 21 (3) : 301 303.
28. Frere P, Pereira M, Fillet G, Beguin Y. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. Eur J Haematol 2006 76 (2) : 102 108.
29. La Rosa AM, Champlin RE, Mirza N, et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001 32 (6) : 871 876.
30. Chakrabarti S, Mautner V, Osman H, et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002 100 (5) : 1619 1627.
31. Symeonidis N, Jakubowski A, Pierre-Louis S, et al. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis 2007 9 (2) : 108 113.
32. Takeshima M, Takamatsu H, Iida M, Mochizuki Y, Okumura H, Yoshida T. Frequent viral infections and delayed CD4+ cell recovery following CD34+ cell-selected autologous peripheral blood stem cell transplantation. Int J Hematol 1999 70 (3) : 193 199.
33. Moore J, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 2002 46 (9) : 2301 2309.
34. Kanda Y, Mineishi S, Saito T, et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001 28 (7) : 689 692.
35. Asano-Mori Y, Kanda Y, Oshima K, et al. Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Am J Hematol 2008 83 (6) : 472 476.